1. Introduction The care of patients undergoing percutaneous coronary intervention (PCI) and the eventual need for early non-cardiac surgery is one of the topics that generates the most debate in perioperative medicine, as it involves important questions about the management of antithrombotic therapy, in addition to the usual management issues of cardiac risk in coronary artery disease. On the one hand, the hemorrhagic risk inherent in surgery and potentiated by antiplatelet agents must be managed. On the other, the increased […]